Drawing for RAVEX

USPTO serial 86625193

RAVEX

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
FOSDICK, GEOFFREY A
Law office
DIVISIONAL UNIT

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with RAVEX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jordan A. LaVine

JORDAN A. LAVINE Flaster Greenberg P C1835 Market StreetSuite 1050Philadelphia, PA 19103

Goods and services

ClassDescriptionStatusFirst use
009Computer software for capturing, managing and reporting data and information in the fields of medical clinical trials and medical research, for designing, managing, and executing medical clinical trials and medical research and medical clinical trial and medical research protocols, for forecasting and benchmarking budgets and costs in medical clinical trials and medical research, for medical coding in medical clinical trials and medical research, for the collection of information and data in medical clinical trials and medical research, for evaluating and measuring the performance and results of medical clinical trials and medical research, for managing, organizing and reporting the results of medical clinical trials and medical research, for monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and medical research, for medical clinical trial and medical research user and learning management, for medical clinical trial and medical research operational reporting and analytics, and for medical clinical trial and medical research patient randomization and supply management; downloadable software in the nature of a mobile application for use in capturing, managing, and reporting data and information in the field of medical clinical trials and research; downloadable software in the nature of a mobile application for use in medical clinical trials, research monitoring and events capture in the nature of gathering and organizing information and data generated in medical clinical trials and researchACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Nov 13, 2017MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 13, 2017ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 18, 2017NOACCORRECTED NOA E-MAILED—
May 17, 2017DPCCDIVISIONAL PROCESSING COMPLETE—
May 16, 2017AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Apr 20, 2017DRRRDIVISIONAL REQUEST RECEIVED—
Apr 20, 2017ERTDTEAS REQUEST TO DIVIDE RECEIVED—
Apr 11, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 7, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 7, 2017EX3GSOU EXTENSION 3 GRANTED—
Apr 7, 2017EXT3SOU EXTENSION 3 FILED—
Apr 7, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 4, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 3, 2016EX2GSOU EXTENSION 2 GRANTED—
Nov 3, 2016AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Oct 13, 2016EXT2SOU EXTENSION 2 FILED—
Oct 13, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 15, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 13, 2016EX1GSOU EXTENSION 1 GRANTED—
Apr 13, 2016EXT1SOU EXTENSION 1 FILED—
Apr 13, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 13, 2015NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Aug 18, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 18, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 29, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 16, 2015PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 16, 2015ALIEASSIGNED TO LIE—
Jul 15, 2015CHPBPOST PUBLICATION AMENDMENT - ENTERED—
Jul 14, 2015APETASSIGNED TO PETITION STAFF—
Jul 9, 2015PPARPOST PUBLICATION AMENDMENT RECEIVED—
Jul 9, 2015PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Jul 1, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 24, 2015DOCKASSIGNED TO EXAMINER—
May 19, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 14, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance